Alcon PanOptix IOL

Cutarelli Vision with locations in Denver, Fort Collins, Colorado Springs and Boulder is excited to offer the Panoptix Lens Implant, developed by Alcon Pharmaceuticals. This revolutionary lens implant may not only help patients see better but live a better quality of life.

The Alcon Panoptix intraocular lens is the first multifocal lens approved by the FDA. This lens allows patient undergoing cataract surgery, to see near, in the distance and even at close with little or no dependence on glasses or contact lenses. In a recent survey, 99% of Panoptix recipients said they would choose the same lens implant again, and 98% said they would recommend it to a friend or family member.

The PanOptix Lens is designed to give patients a full range of vision, with minimal nighttime glare/and or halos associated with similar lens implants of the past. This lens is an excellent option for patients wishing to be spectacle independent, especially if they drive at night.

The PanOptix Trifocal IOL Benefits:

Cutarelli Vision, was among the first practices in the area to implant the Alcon Acrysof IQ PanOptix Trifocal IOL for cataract patients, which allows for a new level of correction of intermediate, near and distance vision.

  • Excellent distance, intermediate and near visual acuity , with little to no dependence on glasses
  • Fewer Glare or halo issues at night, when compared to other implant options.
  • 99%+ of patients said they would choose the same lens again in FDA trial
  • Available in spherical and toric options